These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 15894327
1. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides. Henault M, Lee LN, Evans GF, Zuckerman SH. J Immunol Methods; 2005 May; 300(1-2):93-9. PubMed ID: 15894327 [Abstract] [Full Text] [Related]
2. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists. Kandimalla ER, Bhagat L, Li Y, Yu D, Wang D, Cong YP, Song SS, Tang JX, Sullivan T, Agrawal S. Proc Natl Acad Sci U S A; 2005 May 10; 102(19):6925-30. PubMed ID: 15860583 [Abstract] [Full Text] [Related]
3. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand. Marshall JD, Heeke DS, Gesner ML, Livingston B, Van Nest G. J Leukoc Biol; 2007 Sep 10; 82(3):497-508. PubMed ID: 17565046 [Abstract] [Full Text] [Related]
4. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity. Vollmer J, Weeratna RD, Jurk M, Davis HL, Schetter C, Wüllner M, Wader T, Liu M, Kritzler A, Krieg AM. J Leukoc Biol; 2004 Sep 10; 76(3):585-93. PubMed ID: 15218053 [Abstract] [Full Text] [Related]
5. Heat shock up-regulates TLR9 expression in human B cells through activation of ERK and NF-kappaB signal pathways. Chen W, Wang J, An H, Zhou J, Zhang L, Cao X. Immunol Lett; 2005 Apr 15; 98(1):153-9. PubMed ID: 15790521 [Abstract] [Full Text] [Related]
6. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides. Gantner F, Hermann P, Nakashima K, Matsukawa S, Sakai K, Bacon KB. Eur J Immunol; 2003 Jun 15; 33(6):1576-85. PubMed ID: 12778475 [Abstract] [Full Text] [Related]
7. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Hartmann G, Battiany J, Poeck H, Wagner M, Kerkmann M, Lubenow N, Rothenfusser S, Endres S. Eur J Immunol; 2003 Jun 15; 33(6):1633-41. PubMed ID: 12778481 [Abstract] [Full Text] [Related]
8. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium. Pedersen G, Andresen L, Matthiessen MW, Rask-Madsen J, Brynskov J. Clin Exp Immunol; 2005 Aug 15; 141(2):298-306. PubMed ID: 15996194 [Abstract] [Full Text] [Related]
9. B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides. Jahrsdorfer B, Mühlenhoff L, Blackwell SE, Wagner M, Poeck H, Hartmann E, Jox R, Giese T, Emmerich B, Endres S, Weiner GJ, Hartmann G. Clin Cancer Res; 2005 Feb 15; 11(4):1490-9. PubMed ID: 15746051 [Abstract] [Full Text] [Related]
10. Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients. Rudnicka W, Burakowski T, Warnawin E, Jastrzebska M, Bik M, Kontny E, Chorazy-Massalska M, Radzikowska A, Buler M, Maldyk P, Maslinski W. Eur J Immunol; 2009 May 15; 39(5):1211-20. PubMed ID: 19384869 [Abstract] [Full Text] [Related]
11. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Andersen JM, Al-Khairy D, Ingalls RR. Biol Reprod; 2006 May 15; 74(5):824-31. PubMed ID: 16421230 [Abstract] [Full Text] [Related]
12. Toll-like receptor, MHC II, B7 and cytokine expression by porcine monocytes and monocyte-derived dendritic cells in response to microbial pathogen-associated molecular patterns. Raymond CR, Wilkie BN. Vet Immunol Immunopathol; 2005 Sep 15; 107(3-4):235-47. PubMed ID: 15998543 [Abstract] [Full Text] [Related]
13. Signaling in B cells via Toll-like receptors. Peng SL. Curr Opin Immunol; 2005 Jun 15; 17(3):230-6. PubMed ID: 15886111 [Abstract] [Full Text] [Related]
14. Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88. Senn JJ, Burel S, Henry SP. J Pharmacol Exp Ther; 2005 Sep 15; 314(3):972-9. PubMed ID: 15919763 [Abstract] [Full Text] [Related]
15. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia. Schmitt A, Li L, Giannopoulos K, Greiner J, Reinhardt P, Wiesneth M, Schmitt M. Transfusion; 2008 May 15; 48(5):861-70. PubMed ID: 18208411 [Abstract] [Full Text] [Related]
16. Toll-like receptor 9 suppression in plasmacytoid dendritic cells after IgE-dependent activation is mediated by autocrine TNF-alpha. Schroeder JT, Chichester KL, Bieneman AP. J Allergy Clin Immunol; 2008 Feb 15; 121(2):486-91. PubMed ID: 18036648 [Abstract] [Full Text] [Related]
17. Regulation and signal transduction of toll-like receptors in human chorioncarcinoma cell lines. Klaffenbach D, Rascher W, Röllinghoff M, Dötsch J, Meissner U, Schnare M. Am J Reprod Immunol; 2005 Feb 15; 53(2):77-84. PubMed ID: 15790341 [Abstract] [Full Text] [Related]
18. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production. Giordani L, Sanchez M, Libri I, Quaranta MG, Mattioli B, Viora M. J Leukoc Biol; 2009 Aug 15; 86(2):261-71. PubMed ID: 19401392 [Abstract] [Full Text] [Related]
19. Cathepsins are required for Toll-like receptor 9 responses. Matsumoto F, Saitoh S, Fukui R, Kobayashi T, Tanimura N, Konno K, Kusumoto Y, Akashi-Takamura S, Miyake K. Biochem Biophys Res Commun; 2008 Mar 14; 367(3):693-9. PubMed ID: 18166152 [Abstract] [Full Text] [Related]
20. Expression and function of Toll-like receptors in chicken heterophils. Kogut MH, Iqbal M, He H, Philbin V, Kaiser P, Smith A. Dev Comp Immunol; 2005 Mar 14; 29(9):791-807. PubMed ID: 15936435 [Abstract] [Full Text] [Related] Page: [Next] [New Search]